Silver Book Fact

Medicare patients with sSAS have an average lifespan of 1.8 years without repair or replacement

Fact image

Goel S, Bajaj N, Agaarwall B, Gupta S, et al. Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure. J Am Coll Cardiol. 2014; 63(2). http://www.onlinejacc.org/content/63/2/185

Reference

Title
Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure
Publication
J Am Coll Cardiol
Publication Date
2014
Authors
Goel S, Bajaj N, Agaarwall B, Gupta S, et al.
Volume & Issue
Volume 63, Issue 2
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Related Facts

  • Lifespan of Medicare patients with sSAS who do not undergo treatment
    Medicare patients with severe symptomatic aortic stenosis (sSAS) who do not undergo treatment have an average lifespan of 1.8 years.  
  • All-cause mortality for aortic valve disorders
    In 2014, all-cause mortality for aortic valve disorders was 34,408 in the U.S.  
  • Low detection rates for AS
    Prevalence estimates for AS are likely low. A U.K. population screening found previously undetected HVD in 1 in 2 adults ages 65+.  
  • 2016 prevalence of Americans 65+ who had AVD
    In 2016, an estimated 5.2 million U.S. adults ages 65+ had aortic valve disease (AVD).   Note: Alliance for Aging Research generated statistic, based on 2005 percentage prevalence estimates by Bach et al. 2007  
  • Survival rates for patients with sSAS without repair or replacement